세계의 수술용 가운 및 드레이프 시장 : 제품 유형별, 용도별, 소재별, 멸균 상태별, 적용 분야별, 최종사용자별(-2030년)

The global surgical gowns and drapes market is projected to reach USD 6.01 billion by 2030 from USD 4.69 billion in 2025, at a CAGR of 5.1% during the forecast period. The market is expected to experience high growth due to the rising prevalence of healthcare-associated infections (HAIs), an increase in surgical procedures, and advancements in fabric technologies. The growing focus on infection prevention and patient safety, as well as innovations in antimicrobial and fluid-resistant materials, are driving the demand for high-quality surgical gowns and drapes.

However, concerns over the environmental impact of disposable products and the high cost of premium surgical textiles may restrain market growth. Nonetheless, the continuous improvement in product performance and increasing adoption in hospitals and healthcare facilities are expected to fuel the market expansion.

The hospitals segment is expected to have the largest market during the forecast period.

Based on end user, the market is segmented into hospitals, ambulatory surgical centers, and other end users. In 2024, hospitals accounted for the largest share of the market. The hospital segment is the largest in the surgical gowns and drapes market due to the high volume of surgeries and medical procedures performed in hospitals worldwide. Hospitals are primary settings for surgeries, where maintaining a sterile environment is critical to preventing infections and ensuring patient safety. The demand for surgical gowns and drapes in hospitals is driven by the need for high-quality, reliable infection control products to protect both patients and healthcare professionals. Additionally, hospitals are more likely to adopt advanced materials and technologies, such as fluid-resistant and antimicrobial fabrics, to enhance infection prevention. With a constant need for surgical gowns and drapes in operating rooms, patient care areas, and other clinical settings, the hospital segment remains the largest and most dominant end user in the market.

The general surgery products segment accounted for the largest market share in the surgical gowns and drapes market.

The surgical gowns and drapes market is segmented into general surgery, cardiovascular, gynecology, ophthalmology, lithotomy & laparoscopy, and other applications, based on application. The general surgery segment is the largest in the surgical gowns and drapes market due to the high volume of procedures performed globally. General surgeries, such as appendectomies, gallbladder removals, and hernia repairs, are among the most common medical procedures, driving significant demand for surgical gowns and drapes. These surgeries require strict infection control measures to ensure patient safety, making high-quality surgical textiles essential. The widespread use of disposable gowns and drapes in general surgery helps maintain a sterile environment, reduce the risk of infections, and enhance overall procedural efficiency. As general surgeries continue to be performed at a high rate, this segment remains the dominant driver of growth in the surgical gowns and drapes market.

Asia Pacific is expected to be the fastest-growing market for surgical gowns and drapes during the forecast period.

The global surgical gowns and drapes market is segmented into six segments, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific is expected to be the fastest-growing market for surgical gowns and drapes during the forecast period. The region's rapid urbanization, coupled with growing healthcare infrastructure, has significantly increased the demand for infection control products, including surgical gowns and drapes. As the number of surgeries rises in countries like China, India, and Southeast Asia, the need for high-quality, cost-effective surgical textiles grows. Moreover, the increasing prevalence of healthcare-associated infections (HAIs) and government initiatives aimed at improving healthcare standards are further driving the adoption of surgical gowns and drapes in the region. With a large population base and a growing focus on patient safety, the Asia Pacific is poised to experience substantial growth in this market over the coming years.

North America leads the surgical gowns and drapes market in terms of market size, driven by its advanced healthcare systems and high number of surgical procedures performed annually. The region's well-established healthcare infrastructure, coupled with stringent infection control regulations, has made surgical gowns and drapes essential in maintaining sterile environments during surgeries. Additionally, North America's focus on patient safety and the adoption of advanced fabric technologies, such as antimicrobial and fluid-resistant materials, further boost the demand for these products. The presence of leading manufacturers and significant healthcare expenditure in countries such as the US and Canada ensures that North America remains the dominant market for surgical gowns and drapes.

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier 1: 28%, Tier 2: 42%, and Tier 3: 30%
• By Designation: C Level: 30%, Director Level: 34%, and Others: 36%
• By Region: North America: 51%, Europe: 21%, Asia Pacific: 18%, Latin America: 6%, and Middle East & Africa: 4%
• Note 1: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.

Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.

Note 3: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

The major players operating in the surgical gowns and drapes market are Cardinal Health (US), Owens & Minor (US), Medline Industries, LP. (US), McKesson Corporation (US), and Molnlycke AB (Sweden).

Research Coverage

This report examines the surgical gowns and drapes market in terms of product type, material, sterility, application, end user, and regions. The report also examines key factors (including drivers, restraints, opportunities, and challenges) influencing market growth and provides an in-depth analysis of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets in terms of their individual growth trends. It forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will enable established firms and smaller entrants to gauge the market's pulse, which in turn will help them garner a larger market share. Firms purchasing the report could use one or more strategies mentioned below to strengthen their market presence.

This report provides insights into the following pointers:

Analysis of key Drivers (Growing prevalence of HAIs, Increasing number of surgical procedures, Rising focus on infection prevention protocols, Expansion of ambulatory surgical centers)

Restraints (Reuse of surgical gowns and drapes in developing regions, High cost of premium disposable products)

Opportunities (Growth opportunities in emerging countries, Adoption of advanced fabric technologies)

Challenges (Supply chain volatility in raw materials, Quality inconsistency among low-cost suppliers)

Market Penetration: Comprehensive information on the product portfolios offered by the top players in the surgical gowns and drapes market

Product Development/Innovation: Detailed insights into the upcoming trends, R&D activities, and product launches in the surgical gowns and drapes market

Market Development: Comprehensive information on lucrative emerging regions

Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the surgical gowns and drapes market

Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players, such as Cardinal Health (US), Owens & Minor (US), Medline Industries, LP. (US), McKesson Corporation (US), and Molnlycke AB (Sweden)

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
  • 1.3.2 INCLUSIONS AND EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
• 1.4 CURRENCY CONSIDERED
• 1.5 STAKEHOLDERS
• 1.6 SUMMARY OF CHANGES

2 EXECUTIVE SUMMARY

• 2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS
• 2.2 KEY MARKET PARTICIPANTS: INSIGHTS AND STRATEGIC DEVELOPMENTS
• 2.3 DISRUPTIVE TRENDS SHAPING MARKET
• 2.4 HIGH-GROWTH SEGMENTS AND EMERGING FRONTIERS
• 2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

• 3.1 SURGICAL GOWNS AND DRAPES MARKET OVERVIEW
• 3.2 SURGICAL GOWNS AND DRAPES MARKET, BY PRODUCT TYPE, 2025 VS. 2030
• 3.3 SURGICAL GOWNS AND DRAPES MARKET, BY MATERIAL, 2025 VS. 2030
• 3.4 SURGICAL GOWNS AND DRAPES MARKET, BY STERILITY, 2025 VS. 2030
• 3.5 SURGICAL GOWNS AND DRAPES MARKET, BY APPLICATION, 2025 VS. 2030
• 3.6 SURGICAL GOWNS AND DRAPES MARKET, BY END USER, 2025 VS. 2030
• 3.7 SURGICAL GOWNS AND DRAPES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

4 MARKET OVERVIEW

• 4.1 INTRODUCTION
• 4.2 MARKET DYNAMICS
  • 4.2.1 DRIVERS
    • 4.2.1.1 Rising prevalence of healthcare-associated infections
    • 4.2.1.2 Increasing number of surgical procedures
    • 4.2.1.3 Growing focus on infection prevention protocols
    • 4.2.1.4 Expansion of ambulatory surgical centers
  • 4.2.2 RESTRAINTS
    • 4.2.2.1 Reuse of surgical gowns and drapes in developing regions
    • 4.2.2.2 High cost of premium disposable products
  • 4.2.3 OPPORTUNITIES
    • 4.2.3.1 Growth opportunities in emerging countries
    • 4.2.3.2 Adoption of advanced fabric technologies
  • 4.2.4 CHALLENGES
    • 4.2.4.1 Supply chain volatility in raw materials
    • 4.2.4.2 Quality inconsistency among low-cost suppliers
• 4.3 UNMET NEEDS AND WHITE SPACES
  • 4.3.1 UNMET NEEDS IN SURGICAL GOWNS AND DRAPES MARKET
  • 4.3.2 WHITE SPACE OPPORTUNITIES
• 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
  • 4.4.1 INTERCONNECTED MARKETS
  • 4.4.2 CROSS-SECTOR OPPORTUNITIES
• 4.5 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS
  • 4.5.1 KEY MOVES AND STRATEGIC FOCUS

5 INDUSTRY TRENDS

• 5.1 PORTER'S FIVE FORCES ANALYSIS
  • 5.1.1 THREAT OF NEW ENTRANTS
  • 5.1.2 THREAT OF SUBSTITUTES
  • 5.1.3 BARGAINING POWER OF BUYERS
  • 5.1.4 BARGAINING POWER OF SUPPLIERS
  • 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.2 MACROECONOMIC INDICATORS
  • 5.2.1 INTRODUCTION
  • 5.2.2 GDP TRENDS AND FORECAST
• 5.3 SUPPLY CHAIN ANALYSIS
• 5.4 VALUE CHAIN ANALYSIS
• 5.5 ECOSYSTEM ANALYSIS
• 5.6 PRICING ANALYSIS
  • 5.6.1 AVERAGE SELLING PRICE TREND, BY PRODUCT
  • 5.6.2 AVERAGE SELLING PRICE TREND, BY KEY PLAYER
  • 5.6.3 AVERAGE SELLING PRICE TREND, BY REGION
• 5.7 TRADE ANALYSIS
  • 5.7.1 IMPORT SCENARIO (HS CODE 621010)
  • 5.7.2 EXPORT SCENARIO (HS CODE 621010)
• 5.8 KEY CONFERENCES AND EVENTS, 2025-2026
• 5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
• 5.10 INVESTMENT AND FUNDING SCENARIO
• 5.11 CASE STUDY ANALYSIS
  • 5.11.1 CASE STUDY 1: COST BENEFIT ANALYSIS OF SURGICAL GOWN AND DRAPE SELECTION
  • 5.11.2 CASE STUDY 2: COMPARE IMPACT AND COST-EFFECTIVENESS LONG FIBER POLYESTER VS. COTTON FABRIC DRAPES
  • 5.11.3 CASE STUDY 3: EVALUATE AND COMPARE PERFORMANCE OF DISPOSABLE VS. REUSABLE MEDICAL GOWNS
• 5.12 IMPACT OF 2025 US TARIFFS ON SURGICAL GOWNS AND DRAPES MARKET
  • 5.12.1 INTRODUCTION
  • 5.12.2 KEY TARIFF RATES
  • 5.12.3 PRICE IMPACT ANALYSIS
  • 5.12.4 KEY IMPACT ON COUNTRY/REGION
    • 5.12.4.1 North America
    • 5.12.4.2 Europe
    • 5.12.4.3 Asia Pacific
  • 5.12.5 IMPACT ON END-USE INDUSTRIES
    • 5.12.5.1 Hospitals
    • 5.12.5.2 Ambulatory Surgical Centers (ASCs)

6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

• 6.1 KEY EMERGING TECHNOLOGIES
  • 6.1.1 SMART TEXTILES (E-TEXTILES)
  • 6.1.2 BIODEGRADABLE AND COMPOSTABLE MATERIALS
  • 6.1.3 ANTIMICROBIAL AND ANTIVIRAL COATINGS
• 6.2 COMPLEMENTARY TECHNOLOGIES
  • 6.2.1 STERILIZATION TECHNOLOGIES
  • 6.2.2 REUSABLE SURGICAL TEXTILES
• 6.3 TECHNOLOGY/PRODUCT ROADMAP
  • 6.3.1 SHORT-TERM (2025-2027) | PROCESS IMPROVEMENT & STANDARDIZATION
  • 6.3.2 MID-TERM (2027-2030) | MATERIAL DIVERSIFICATION & SUSTAINABILITY
  • 6.3.3 LONG-TERM (2030-2035+) | HIGH-PERFORMANCE & ECO-EFFICIENT LABWARE
• 6.4 TECHNOLOGY/PRODUCT ROADMAP
• 6.5 PATENT ANALYSIS
• 6.6 FUTURE APPLICATIONS
• 6.7 IMPACT OF AI/GENERATIVE AI ON SURGICAL GOWNS AND DRAPES MARKET
  • 6.7.1 TOP USE CASES AND MARKET POTENTIAL
  • 6.7.2 BEST PRACTICES IN SURGICAL GOWNS AND DRAPES MARKET
  • 6.7.3 FUTURE OF AI IN SURGICAL GOWNS AND DRAPES MARKET

7 SUSTAINABILITY AND REGULATORY LANDSCAPE

• 7.1 REGIONAL REGULATIONS AND COMPLIANCE
  • 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 7.1.2 INDUSTRY STANDARDS
• 7.2 SUSTAINABILITY INITIATIVES
  • 7.2.1 ENVIRONMENTAL IMPACT AND ECO-FRIENDLY INITIATIVES IN SURGICAL GOWNS AND DRAPES
• 7.3 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES

8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

• 8.1 DECISION-MAKING PROCESS
• 8.2 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
  • 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 8.2.2 BUYING CRITERIA
• 8.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES
• 8.4 UNMET NEEDS IN VARIOUS END-USE INDUSTRIES
• 8.5 MARKET PROFITABILITY
  • 8.5.1 REVENUE POTENTIAL
  • 8.5.2 COST DYNAMICS
  • 8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS

9 SURGICAL GOWNS AND DRAPES MARKET, BY PRODUCT TYPE

• 9.1 INTRODUCTION
• 9.2 SURGICAL DRAPES
  • 9.2.1 DISPOSABLE DRAPES
    • 9.2.1.1 Increasing volume of surgeries and growing focus on infection prevention to drive market
  • 9.2.2 REUSABLE DRAPES
    • 9.2.2.1 Durability and sustainability to contribute to growth
• 9.3 SURGICAL GOWNS
  • 9.3.1 USAGE PATTERN
    • 9.3.1.1 Disposable gowns
      • 9.3.1.1.1 Convenience and single-use nature to foster growth
    • 9.3.1.2 Reusable gowns
      • 9.3.1.2.1 Long-term cost-effectiveness to encourage growth
  • 9.3.2 TYPE
    • 9.3.2.1 Standard performance gowns
      • 9.3.2.1.1 Increasing use of standard performance gowns in low-risk procedures to favor growth
    • 9.3.2.2 Reinforced gowns
      • 9.3.2.2.1 Rising demand for reinforced gowns to protect healthcare workers during moderate-risk surgical procedures to boost market
    • 9.3.2.3 High-performance gowns
      • 9.3.2.3.1 Lightweight and breathable properties to accelerate growth

10 SURGICAL GOWNS AND DRAPES MARKET: VOLUME ANALYSIS

• 10.1 INTRODUCTION
  • 10.1.1 US: TOTAL VOLUME OF SURGICAL DRAPES, BY APPLICATION, 2023-2030 (MILLION UNITS)
  • 10.1.2 US: TOTAL VOLUME OF SURGICAL GOWNS, BY APPLICATION, 2023-2030 (MILLION UNITS)

11 SURGICAL GOWNS AND DRAPES MARKET, BY MATERIAL

• 11.1 INTRODUCTION
• 11.2 NON-WOVEN MATERIALS
  • 11.2.1 POLYPROPYLENE (PP)
    • 11.2.1.1 Ability to offer varying degrees of fluid resistance, breathability, and comfort to fuel market
  • 11.2.2 POLYETHYLENE (PE)
    • 11.2.2.1 Low-friction surface and ease of manufacturing to spur growth
  • 11.2.3 SPUNBOND-MELTBLOWN-SPUNBOND (SMS)
    • 11.2.3.1 Enhanced durability and resistance to stimulate growth
  • 11.2.4 SPUNLACE MATERIALS
    • 11.2.4.1 Growing adoption of non-wovens in single-use medical barriers to drive market
  • 11.2.5 OTHER NON-WOVEN MATERIALS
• 11.3 WOVEN FABRICS
  • 11.3.1 COTTON
    • 11.3.1.1 Improved air circulation and compatibility with sensitive skin to boost market
  • 11.3.2 POLYESTER-COTTON BLENDS
    • 11.3.2.1 Higher resistance to wrinkles, abrasion, and shrinkage to aid growth
  • 11.3.3 POLYESTER
    • 11.3.3.1 High level of structural integrity to favor growth
  • 11.3.4 MICROFIBER FABRICS
    • 11.3.4.1 Growing patient volume to drive market
  • 11.3.5 LAMINATED/COATED MATERIALS
    • 11.3.5.1 Enhanced protective qualities and durability to promote growth
• 11.4 BIODEGRADABLE MATERIALS
  • 11.4.1 RISING GERIATRIC POPULATION AND HIGH INCIDENCE OF EPILEPSY TO DRIVE MARKET

12 SURGICAL GOWNS AND DRAPES MARKET, BY STERILITY

• 12.1 INTRODUCTION
• 12.2 STERILE PRODUCTS
  • 12.2.1 INCREASING FOCUS ON REDUCING RISK OF INFECTIONS TO AID GROWTH
• 12.3 NON-STERILE PRODUCTS
  • 12.3.1 RISING POPULARITY IN PATIENT WARDS AND EMERGENCY ROOMS TO EXPEDITE GROWTH

13 SURGICAL GOWNS AND DRAPES MARKET, BY APPLICATION

• 13.1 INTRODUCTION
• 13.2 CARDIOVASCULAR APPLICATIONS
  • 13.2.1 GROWING INCIDENCE OF CARDIOVASCULAR DISEASES TO FUEL MARKET
• 13.3 GENERAL SURGERY
  • 13.3.1 INCREASING VOLUME OF GENERAL SURGERIES TO SPUR GROWTH
• 13.4 GYNECOLOGY
  • 13.4.1 RISING C-SECTION AND HYSTERECTOMY CASES TO BOLSTER GROWTH
• 13.5 OPHTHALMOLOGY
  • 13.5.1 INCREASING PREVALENCE OF EYE CONDITIONS TO AID GROWTH
• 13.6 LITHOTOMY & LAPAROSCOPY
  • 13.6.1 QUICK RECOVERY TIMES AND REDUCED COMPLICATIONS TO FACILITATE GROWTH
• 13.7 OTHER APPLICATIONS

14 SURGICAL GOWNS AND DRAPES MARKET, BY END USER

• 14.1 INTRODUCTION
• 14.2 HOSPITALS
  • 14.2.1 INCREASING NUMBER OF SURGERIES PERFORMED GLOBALLY TO PROMOTE GROWTH
• 14.3 AMBULATORY SURGICAL CENTERS
  • 14.3.1 RISING FOCUS ON IMPROVED CARE QUALITY AND REDUCED PROCEDURAL COSTS TO BOOST MARKET
• 14.4 OTHER END USERS

15 SURGICAL GOWNS AND DRAPES MARKET, BY REGION

• 15.1 INTRODUCTION
• 15.2 NORTH AMERICA
  • 15.2.1 US
    • 15.2.1.1 Growing cases of healthcare-associated infections to drive market
  • 15.2.2 CANADA
    • 15.2.2.1 Rising geriatric population to support growth
• 15.3 EUROPE
  • 15.3.1 GERMANY
    • 15.3.1.1 Growing adoption of hospital disinfection and surveillance systems to boost market
  • 15.3.2 UK
    • 15.3.2.1 Increasing focus on comprehensive, data-driven infection control strategies to fuel market
  • 15.3.3 FRANCE
    • 15.3.3.1 Stringent regulatory guidelines for infection control product commercialization to aid growth
  • 15.3.4 ITALY
    • 15.3.4.1 Increasing establishment of long-term care facilities to boost market
  • 15.3.5 SPAIN
    • 15.3.5.1 Increasing incidence of chronic diseases to spur growth
  • 15.3.6 REST OF EUROPE
• 15.4 ASIA PACIFIC
  • 15.4.1 JAPAN
    • 15.4.1.1 Increasing elderly population and healthcare expenditure to drive market
  • 15.4.2 CHINA
    • 15.4.2.1 Rising healthcare spending and increasing prevalence of chronic diseases to drive market
  • 15.4.3 INDIA
    • 15.4.3.1 Extensive patient population to contribute to growth
  • 15.4.4 AUSTRALIA
    • 15.4.4.1 Increasing demand for healthcare services to facilitate growth
  • 15.4.5 REST OF ASIA PACIFIC
• 15.5 LATIN AMERICA
  • 15.5.1 BRAZIL
    • 15.5.1.1 Robust pharmaceutical and biotechnology industries to drive market
  • 15.5.2 MEXICO
    • 15.5.2.1 Changing demographic trend to encourage growth
  • 15.5.3 REST OF LATIN AMERICA
• 15.6 MIDDLE EAST & AFRICA

16 COMPETITIVE LANDSCAPE

• 16.1 OVERVIEW
• 16.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2022-2025
• 16.3 REVENUE ANALYSIS, 2022-2024
• 16.4 MARKET SHARE ANALYSIS, 2024
• 16.5 BRAND/PRODUCT COMPARISON
• 16.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 16.6.1 STARS
  • 16.6.2 EMERGING LEADERS
  • 16.6.3 PERVASIVE PLAYERS
  • 16.6.4 PARTICIPANTS
  • 16.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
    • 16.6.5.1 Company footprint
    • 16.6.5.2 Region footprint
    • 16.6.5.3 Product type footprint
    • 16.6.5.4 Application footprint
    • 16.6.5.5 End-user footprint
• 16.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
  • 16.7.1 PROGRESSIVE COMPANIES
  • 16.7.2 RESPONSIVE COMPANIES
  • 16.7.3 DYNAMIC COMPANIES
  • 16.7.4 STARTING BLOCKS
  • 16.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    • 16.7.5.1 Detailed list of key startups/SMEs
    • 16.7.5.2 Competitive benchmarking of key startups/SMEs
• 16.8 COMPANY VALUATION AND FINANCIAL METRICS
• 16.9 COMPETITIVE SCENARIO
  • 16.9.1 PRODUCT LAUNCHES AND APPROVALS
  • 16.9.2 DEALS
  • 16.9.3 EXPANSIONS
  • 16.9.4 OTHER DEVELOPMENTS

17 COMPANY PROFILES

• 17.1 KEY PLAYERS
  • 17.1.1 CARDINAL HEALTH
    • 17.1.1.1 Business overview
    • 17.1.1.2 Products offered
    • 17.1.1.3 Recent developments
      • 17.1.1.3.1 Product launches and approvals
      • 17.1.1.3.2 Expansions
    • 17.1.1.4 MnM view
      • 17.1.1.4.1 Key strengths/Right to win
      • 17.1.1.4.2 Strategic choices
      • 17.1.1.4.3 Weaknesses/Competitive threats
  • 17.1.2 MEDLINE INDUSTRIES, LP
    • 17.1.2.1 Business overview
    • 17.1.2.2 Products offered
    • 17.1.2.3 Recent developments
      • 17.1.2.3.1 Deals
      • 17.1.2.3.2 Other developments
    • 17.1.2.4 MnM view
      • 17.1.2.4.1 Key strengths/Right to win
      • 17.1.2.4.2 Strategic choices
      • 17.1.2.4.3 Weaknesses/Competitive threats
  • 17.1.3 OWENS & MINOR
    • 17.1.3.1 Business overview
    • 17.1.3.2 Products offered
    • 17.1.3.3 MnM view
      • 17.1.3.3.1 Key strengths/Right to win
      • 17.1.3.3.2 Strategic choices
      • 17.1.3.3.3 Weaknesses/Competitive threats
  • 17.1.4 MCKESSON CORPORATION
    • 17.1.4.1 Business overview
    • 17.1.4.2 Products offered
    • 17.1.4.3 MnM view
      • 17.1.4.3.1 Key strengths/Right to win
      • 17.1.4.3.2 Strategic choices
      • 17.1.4.3.3 Weaknesses/Competitive threats
  • 17.1.5 MOLNLYCKE AB
    • 17.1.5.1 Business overview
    • 17.1.5.2 Products offered
    • 17.1.5.3 MnM view
      • 17.1.5.3.1 Key strengths/Right to win
      • 17.1.5.3.2 Strategic choices
      • 17.1.5.3.3 Weaknesses/Competitive threats
  • 17.1.6 SOLVENTUM
    • 17.1.6.1 Business overview
    • 17.1.6.2 Products offered
    • 17.1.6.3 Recent developments
      • 17.1.6.3.1 Other developments
  • 17.1.7 PAUL HARTMANN AG
    • 17.1.7.1 Business overview
    • 17.1.7.2 Products offered
    • 17.1.7.3 Recent developments
      • 17.1.7.3.1 Deals
  • 17.1.8 WINNER MEDICAL, CO., LTD.
    • 17.1.8.1 Business overview
    • 17.1.8.2 Products offered
    • 17.1.8.3 Recent developments
      • 17.1.8.3.1 Deals
  • 17.1.9 STERIS
    • 17.1.9.1 Business overview
    • 17.1.9.2 Products offered
  • 17.1.10 ALPHAPROTECH
    • 17.1.10.1 Business overview
    • 17.1.10.2 Products offered
  • 17.1.11 HENRY SCHEIN
    • 17.1.11.1 Business overview
    • 17.1.11.2 Products offered
  • 17.1.12 B.BRAUN SE
    • 17.1.12.1 Business overview
    • 17.1.12.2 Products offered
  • 17.1.13 BOSTON SCIENTIFIC CORPORATION
    • 17.1.13.1 Business overview
    • 17.1.13.2 Products offered
• 17.2 OTHER PLAYERS
  • 17.2.1 LOHMANN & RAUSCHER GMBH & CO. KG
  • 17.2.2 STANDARD TEXTILE CO., INC.
  • 17.2.3 PLURITEX S.R.L.
  • 17.2.4 MEDICA EUROPE BV
  • 17.2.5 AMARYLLIS HEALTHCARE PVT. LTD.
  • 17.2.6 STERIMED GROUP
  • 17.2.7 GPC MEDICAL
  • 17.2.8 ALLESET
  • 17.2.9 BOEN HEALTHCARE CO., LTD.
  • 17.2.10 PRIONTEX
  • 17.2.11 EURONDA SPA
  • 17.2.12 TIDI PRODUCTS, LLC.

18 RESEARCH METHODOLOGY

• 18.1 RESEARCH DATA
  • 18.1.1 SECONDARY DATA
    • 18.1.1.1 List of secondary sources
    • 18.1.1.2 Key data from secondary sources
  • 18.1.2 PRIMARY DATA
    • 18.1.2.1 List of primary sources
    • 18.1.2.2 Key data from primary sources
    • 18.1.2.3 Breakdown of primary interviews
    • 18.1.2.4 Key industry insights
• 18.2 MARKET SIZE ESTIMATION
  • 18.2.1 BOTTOM-UP APPROACH
    • 18.2.1.1 Approach 1: Revenue estimation of key players
    • 18.2.1.2 Approach 2: Study of annual reports and investor presentations
    • 18.2.1.3 Approach 3: Primary interviews
    • 18.2.1.4 Growth forecast
    • 18.2.1.5 CAGR projections
  • 18.2.2 TOP-DOWN APPROACH
• 18.3 DATA TRIANGULATION
• 18.4 RESEARCH ASSUMPTIONS
  • 18.4.1 STUDY-RELATED ASSUMPTIONS
  • 18.4.2 PARAMETRIC ASSUMPTIONS
  • 18.4.3 GROWTH RATE ASSUMPTIONS
• 18.5 RESEARCH LIMITATIONS AND RISK ASSESSMENT
  • 18.5.1 RESEARCH LIMITATIONS
  • 18.5.2 RISK ASSESSMENT

19 APPENDIX

• 19.1 DISCUSSION GUIDE
• 19.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 19.3 CUSTOMIZATION OPTIONS
• 19.4 RELATED REPORTS
• 19.5 AUTHOR DETAILS